LUIS LOZANO: Open Payments
NPI 1477172336 · GREEN VALLEY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,256 in 16 payments from 9 companies in 2025. Trend: 2023 $137 · 2024 $542 · 2025 $4,256
Long term medical supply or device loan: $3,328Food & beverage: $928
| Company | Payments | Amount |
|---|---|---|
| INTERNATIONAL REHABILITATIVE SCIENCES, INC | 1 | $3,328 |
| AstraZeneca Pharmaceuticals LP | 6 | $249 |
| Penumbra, Inc. | 1 | $171 |
| E.R. Squibb & Sons, L.L.C. | 2 | $123 |
| Novo Nordisk Inc | 1 | $122 |
| ABBVIE INC. | 2 | $121 |
| CVRx, Inc. | 1 | $98 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Boston Scientific Corporation | 1 | $22 |
Products named: RS-4i Plus with Intersperse, BREZTRI, Indigo System, COBENFY, Ozempic, VRAYLAR, Barostim Neo System, GVOKE HYPOPEN.
Industry payments across AZ — which companies pay providers there.
